Publications by authors named "E Sher"

Claim this Profile
T
Tralokinumab for moderate-to-severe atopic dermatitis: A viable option for dupilumab nonresponders.
Christine T Olagun-Samuel, Christine C Akoh, Nnaemeka Anyanwu, Elizabeth F Sher, Carli D Needle

JAAD Int· February 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oxidative Stress-Induced mechanisms in neurodegeneration and Eryptosis: Implications for neurological and systemic disorders.
Marijana Markovic Boras, Vanja Krulj, Alma Karahmet, Kanita Omerbasic, Asma Nawaz, Emina K Sher

Brain Res· February 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood pressure effects of SGLT2 inhibitors and GLP-1 receptor agonists: Mechanisms, trial evidence and Real-world data.
Andrej Belančić, Yusuf Ziya Sener, Marijana Vučković, Joseph Edgar Blais, Almir Fajkić, Emina Sher

Br J Clin Pharmacol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lebrikizumab is Efficacious in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis Regardless of Atopic Comorbidities.
Ellen R Sher, Alexandra Golant, Marjolein de Bruin-Weller, Jose-Manuel Carrascosa, Vinay Mehta

Ann Allergy Asthma Immunol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting DNA Polymerase Epsilon Leads to Tumor Clearance and Activation of an NF-κB-mediated inflammatory response in Triple Negative Breast Cancer.
Elizabeth F Sher, Kenji M Fujihara, Anthony Tao, Diana Erenburg, Vladislav O Sviderskiy

bioRxiv· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis